出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年6月
近赤外画像市場 : 製品 [イメージングシステム、プローブ、色素 (有機、ナノ粒子)]、手順 (がん、CVD、GI、産婦人科)、用途 (前臨床、臨床、医療)、エンドユーザー (病院、製薬、研究室) 、地域別 – 2028年までの世界予測
Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region – Global Forecast to 2028
| ページ数 | 233 |
| 図表数 | 236 |
| 種別 | 英文調査報告書 |
| 価格 |
The global near infrared imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.0 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the high incidence/prevalence of target diseases, growing number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early diagnosis of diseases, and the rapid adoption of technologically advanced NIR modalities are responsible for the increasing growth of this market.
“The near-infrared fluorescence imaging sub-systems segment of NIR devices segment held the largest share of the market in 2022”
Based on product, the near-infrared imaging market is segmented into NIR devices, NIR imaging agents/probes and NIR dyes. The NIR devices segment of the market is further divided into near-infrared fluorescence imaging systems and near-infrared fluorescence & bioluminescence imaging systems. The near-infrared fluorescence imaging systems subsegment held a major share in the market. Advantages offered by near-infrared fluorescence imaging systems, such as high sensitivity, high-image resolution, and real-time image guidance during surgeries, are driving the growth of this product segment.
“The preclinical applications segment is projected to register the highest CAGR during the forecast period”
Based on application, the near infrared imaging market is broadly categorized into preclinical, clinical and medical. Preclinical imaging refers to the visualization of living animals for research purposes, such as for drug development. It helps scientists to detect and monitor biological mechanisms and to accurately measure and provide therapeutic responses within the body. The growing focus on developing new treatments for diseases/conditions such as cancer, inflammation, angiogenesis, infections, and vascular diseases is expected to drive the growth of this application segment during the forecast period.
“The cancer surgeries segment is projected to register the highest CAGR during the forecast period”
Based on procedure, the near infrared imaging market is broadly categorized into cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, plastic/reconstructive surgeries, and brain tumor surgeries. The rising prevalence of cancer across the globe is the major factor driving the growth of this segment.
“The market in the North America region is expected to witness the highest growth during the forecast period.”
The near infrared imaging market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: Director-level–14%, C-level–10%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The prominent players in the near infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Medtronic (Ireland) among others.
Research Coverage
This report studies the near infrared imaging market based on product, procedure, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall near infrared imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
• Analysis of key drivers (rising target patient population, growing adoption of multimodal PET imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, PET utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the near infrared imaging market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the near infrared imaging market
• Market Development: Comprehensive information about lucrative markets–the report analyses the near infrared imaging market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the near infrared imaging market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), and Medtronic (Ireland).
目次
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 24
1.3 MARKETS COVERED 25
1.3.1 MARKET SEGMENTATION 25
1.3.2 REGIONAL SEGMENTATION 25
1.4 YEARS CONSIDERED 26
1.5 CURRENCY CONSIDERED 26
1.6 RESEARCH LIMITATIONS 26
1.7 STAKEHOLDERS 27
1.8 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 1 NEAR INFRARED IMAGING MARKET: RESEARCH DESIGN 28
2.1.1 SECONDARY RESEARCH 29
2.1.2 PRIMARY RESEARCH 30
2.1.2.1 Primary sources 30
2.1.2.2 Key industry insights 31
2.1.2.3 Breakdown of primaries 32
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND SIDE PARTICIPANTS 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.2 MARKET SIZE ESTIMATION 32
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.2.1 BOTTOM-UP APPROACH 34
2.2.1.1 Approach 1: Company revenue estimation approach 34
FIGURE 5 APPROACH 1: MARKET SIZE ESTIMATION (COMPANY REVENUE ESTIMATION) 34
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF STRYKER 35
2.2.1.2 Approach 2: Customer-based market estimation 35
FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH 36
2.2.1.3 CAGR projections 36
FIGURE 8 CAGR PROJECTION: SUPPLY SIDE ANALYSIS 36
2.3 DATA TRIANGULATION 37
FIGURE 9 DATA TRIANGULATION METHODOLOGY 37
2.4 MARKET SHARE ASSESSMENT 38
2.5 STUDY ASSUMPTIONS 38
2.6 RISK ASSESSMENT 38
2.6.1 NEAR-INFRARED IMAGING MARKET: RISK ASSESSMENT 38
2.7 GROWTH RATE ASSUMPTIONS 39
2.8 NEAR-INFRARED IMAGING MARKET: RECESSION IMPACT 39
3 EXECUTIVE SUMMARY 40
FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 40
FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 41
FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION) 42
FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 14 GEOGRAPHICAL SNAPSHOT: NEAR-INFRARED IMAGING MARKET 44
4 PREMIUM INSIGHTS 45
4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW 45
FIGURE 15 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET 45
4.2 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT (2023 VS. 2028) 46
FIGURE 16 DEVICES SEGMENT TO DOMINATE NORTH AMERICAN NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD 46
4.3 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER (2023 VS. 2028) 46
FIGURE 17 HOSPITALS & SURGICAL CLINICS TO FORM LARGEST END USER SEGMENT IN ASIA PACIFIC MARKET 46
4.4 GLOBAL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE (2023 VS. 2028) 47
FIGURE 18 FLUORESCENCE IMAGING SYSTEMS SEGMENT TO HOLD LARGEST SHARE DURING STUDY PERIOD 47
4.5 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET 47
FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 20 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Increasing number of surgical procedures globally 49
5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods 50
TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS 50
5.2.1.3 Technological advancements in near-infrared imaging modalities 50
5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging 51
5.2.2 RESTRAINTS 51
5.2.2.1 Lengthy approval process of near-infrared fluorophores 51
5.2.2.2 High initial capital and operational costs of near-infrared systems 52
5.2.2.3 Availability of alternate technologies 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Growth potential for major players in emerging economies 52
5.2.3.2 Use of blockchain for distribution and storage of medical images 53
5.2.4 CHALLENGES 53
5.2.4.1 Hospital budget cuts 53
5.2.4.2 Dearth of trained professionals in emerging economies 53
5.3 PORTER’S FIVE FORCES ANALYSIS 54
TABLE 2 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 54
5.3.1 THREAT OF NEW ENTRANTS 55
5.3.2 THREAT OF SUBSTITUTES 55
5.3.3 BARGAINING POWER OF SUPPLIERS 55
5.3.4 BARGAINING POWER OF BUYERS 55
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 55
5.4 REGULATORY ANALYSIS 56
5.4.1 NORTH AMERICA 56
5.4.1.1 US 56
TABLE 3 US: APPROVED IMAGING DEVICES BY FDA 56
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 57
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 57
5.4.1.2 Canada 58
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58
5.4.2 EUROPE 58
5.4.3 ASIA PACIFIC 59
5.4.3.1 Japan 59
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 59
5.4.3.2 China 60
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 60
5.4.3.3 India 61
5.5 REIMBURSEMENT SCENARIO ANALYSIS 61
TABLE 9 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (AS OF 2021) 62
5.6 ECOSYSTEM MAPPING 62
5.7 VALUE CHAIN ANALYSIS 63
5.7.1 RESEARCH & PRODUCT DEVELOPMENT 63
5.7.2 RAW MATERIAL AND MANUFACTURING 63
5.7.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES 63
FIGURE 21 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 64
5.8 SUPPLY CHAIN ANALYSIS 64
5.8.1 PROMINENT COMPANIES 64
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES 64
5.8.3 END USERS 64
TABLE 10 SUPPLY CHAIN ECOSYSTEM OF NEAR-INFRARED IMAGING MARKET 65
FIGURE 22 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS 66
5.9 PATENT ANALYSIS 67
FIGURE 23 PATENT DETAILS FOR NEAR-INFRARED IMAGING (JANUARY 2013–MAY 2023) 67
FIGURE 24 PATENT DETAILS FOR NEAR-INFRARED FLUORESCENCE IMAGING SYSTEMS (JANUARY 2013–MAY 2023) 68
FIGURE 25 PATENT DETAILS FOR NEAR-INFRARED DYES (JANUARY 2013–MAY 2023) 69
5.10 TRADE ANALYSIS 70
5.10.1 TRADE ANALYSIS: NEAR-INFRARED IMAGING MARKET 70
TABLE 11 IMPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD) 70
TABLE 12 EXPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD) 70
5.11 KEY CONFERENCES AND EVENTS (2023–2025) 71
TABLE 13 NEAR-INFRARED IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025) 71
5.12 TECHNOLOGY ANALYSIS 72
5.13 CASE STUDY ANALYSIS 73
5.13.1 TECHNOLOGICAL CHALLENGES 73
TABLE 14 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 73
5.13.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING 73
TABLE 15 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES 73
5.14 PRICING ANALYSIS 74
TABLE 16 REGION-WISE PRICE RANGE FOR NEAR-INFRARED IMAGING SYSTEMS 74
6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 17 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 76
6.2 DEVICES 76
TABLE 18 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 76
TABLE 19 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 20 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY APPLICATION, 2021–2028 (USD MILLION) 77
TABLE 21 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 78
TABLE 22 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY END USER, 2021–2028 (USD MILLION) 78
6.2.1 FLUORESCENCE IMAGING SYSTEMS 78
6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market 78
TABLE 23 FLUORESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 79
6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS 80
6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market 80
TABLE 24 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.3 NIR IMAGING AGENTS/PROBES 81
TABLE 25 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 81
TABLE 26 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY REGION, 2021–2028 (USD MILLION) 82
TABLE 27 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY APPLICATION, 2021–2028 (USD MILLION) 82
TABLE 28 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY PROCEDURE, 2021–2028 (USD MILLION) 83
TABLE 29 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY END USER, 2021–2028 (USD MILLION) 83
6.3.1 INDOCYANINE GREEN 84
6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segment 84
TABLE 30 INDOCYANINE GREEN MARKET, BY REGION, 2021–2028 (USD MILLION) 84
6.3.2 OTHER REAGENTS 85
6.3.2.1 Other reagents to provide specific functionalities and properties for better imaging process 85
TABLE 31 OTHER REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 85
6.4 NIR DYES 85
TABLE 32 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 33 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 34 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY APPLICATION, 2021–2028 (USD MILLION) 87
TABLE 35 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY PROCEDURE, 2021–2028 (USD MILLION) 87
TABLE 36 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY END USER, 2021–2028 (USD MILLION) 88
6.4.1 ORGANIC DYES 88
6.4.1.1 Unique molecular structure and better compatibility with biological systems to drive segment 88
TABLE 37 ORGANIC DYES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
6.4.2 NANOPARTICLE DYES 89
6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to drive segment 89
TABLE 38 NANOPARTICLE DYES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE 91
7.1 INTRODUCTION 92
TABLE 39 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 92
7.2 CANCER SURGERIES 92
TABLE 40 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 41 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2021–2028 (USD MILLION) 93
7.2.1 BRAIN CANCER/TUMOR SURGERIES 94
7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market 94
TABLE 42 BRAIN CANCER/TUMOR SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 94
7.2.2 OTHER CANCER SURGERIES 95
7.2.2.1 Better tissue penetration and lower autofluorescence levels to drive market 95
TABLE 43 OTHER CANCER SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
7.3 GASTROINTESTINAL SURGERIES 96
TABLE 44 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 45 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2021–2028 (USD MILLION) 97
7.3.1 COLORECTAL SURGERIES 97
7.3.1.1 Advancements in treatment strategies and procedures to drive market 97
TABLE 46 COLORECTAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
7.3.2 OTHER GASTROINTESTINAL SURGERIES 98
7.3.2.1 Precise visualization of near-infrared imaging to drive market 98
TABLE 47 OTHER GASTROINTESTINAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
7.4 CARDIOVASCULAR DISEASES 99
7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET 99
TABLE 48 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 100
7.5 PLASTIC/RECONSTRUCTIVE SURGERIES 100
7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO DRIVE MARKET 100
TABLE 49 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2021–2028 (USD MILLION) 101
7.6 OBSTETRICS & GYNECOLOGY SURGERIES 101
7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO DRIVE MARKET 101
TABLE 50 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2021–2028 (USD MILLION) 102
7.7 OTHER PROCEDURES 103
TABLE 51 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2021–2028 (USD MILLION) 103
8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 52 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
8.2 PRECLINICAL IMAGING 105
8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET 105
TABLE 53 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION) 106
8.3 CLINICAL IMAGING 106
8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO DRIVE MARKET 106
TABLE 54 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION) 107
8.4 MEDICAL IMAGING 107
8.4.1 APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET 107
TABLE 55 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING, BY REGION, 2021–2028 (USD MILLION) 108
9 NEAR-INFRARED IMAGING MARKET, BY END USER 109
9.1 INTRODUCTION 110
TABLE 56 NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 110
9.2 HOSPITALS & SURGICAL CLINICS 110
9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET 110
TABLE 57 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2021–2028 (USD MILLION) 111
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 111
9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO DRIVE MARKET 111
TABLE 58 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 112
9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 112
9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO DRIVE MARKET 112
TABLE 59 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 113
9.5 OTHER END USERS 114
TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 114
10 NEAR-INFRARED IMAGING MARKET, BY REGION 115
10.1 INTRODUCTION 116
TABLE 61 NEAR-INFRARED IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 116
10.2 NORTH AMERICA 117
FIGURE 26 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT 117
TABLE 62 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 63 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 118
TABLE 64 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 65 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 66 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 67 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 68 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 120
TABLE 69 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 120
10.2.1 US 121
10.2.1.1 Advanced healthcare infrastructure and favorable regulations to drive market 121
TABLE 70 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 121
TABLE 71 US: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 72 US: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 73 US: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 122
10.2.2 CANADA 123
10.2.2.1 Increased availability of research funding to drive market 123
TABLE 74 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 123
TABLE 75 CANADA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 76 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 77 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 124
10.3 EUROPE 125
TABLE 78 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 79 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 125
TABLE 80 EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 81 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 82 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 83 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 84 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 127
TABLE 85 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.3.1 GERMANY 128
10.3.1.1 Increasing healthcare expenditure and government spending to drive market 128
TABLE 86 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 129
TABLE 87 GERMANY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 88 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 89 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 130
10.3.2 FRANCE 130
10.3.2.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market 130
TABLE 90 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 131
TABLE 91 FRANCE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 92 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 93 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 132
10.3.3 UK 132
10.3.3.1 Growing government initiatives and increasing incidences of chronic diseases to drive market 132
TABLE 94 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 132
TABLE 95 UK: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 96 UK: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 97 UK: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 133
10.3.4 ITALY 134
10.3.4.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market 134
TABLE 98 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 134
TABLE 99 ITALY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 100 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 101 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR DYE, BY TYPE, 2021–2028 (USD MILLION) 135
10.3.5 SPAIN 136
10.3.5.1 Increasing prevalence of cancer and growing private-public funding to drive market 136
TABLE 102 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 103 SPAIN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 104 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 105 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 137
10.3.6 REST OF EUROPE 138
TABLE 106 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 107 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 108 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 109 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 139
10.4 ASIA PACIFIC 140
FIGURE 27 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT 140
TABLE 110 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 111 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 112 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 113 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 114 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 115 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 116 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 143
TABLE 117 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.4.1 CHINA 144
10.4.1.1 Increasing healthcare reforms and government investments to drive market 144
TABLE 118 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 145
TABLE 119 CHINA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 120 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 121 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 146
10.4.2 JAPAN 146
10.4.2.1 Fast adoption of advanced technologies and growth in geriatric population to drive market 146
TABLE 122 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 123 JAPAN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 124 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 125 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 148
10.4.3 INDIA 148
10.4.3.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market 148
TABLE 126 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 127 INDIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 128 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 129 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 150
10.4.4 AUSTRALIA 150
10.4.4.1 Growing healthcare spending and increasing investments in research to drive market 150
TABLE 130 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 131 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 132 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 133 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 152
10.4.5 SOUTH KOREA 152
10.4.5.1 Presence of advanced healthcare system and increased awareness about diseases to drive market 152
TABLE 134 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 135 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 136 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 137 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 154
10.4.6 REST OF ASIA PACIFIC 154
TABLE 138 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 155
TABLE 139 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 140 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 141 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 156
10.5 LATIN AMERICA 157
TABLE 142 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 143 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 144 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 145 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 146 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 147 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 148 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 159
TABLE 149 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.5.1 BRAZIL 160
10.5.1.1 Greater purchasing power and more favorable demographic conditions to drive market 160
TABLE 150 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 151 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 152 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 153 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 161
10.5.2 MEXICO 162
10.5.2.1 Increased medical tourism and better government healthcare initiatives to drive market 162
TABLE 154 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 155 MEXICO: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 156 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 157 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 163
10.5.3 REST OF LATIN AMERICA 163
TABLE 158 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 159 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 160 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 161 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 165
10.6 MIDDLE EAST & AFRICA 165
10.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET 165
TABLE 162 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 163 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 164 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 165 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 166 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 167 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 168
TABLE 168 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11 COMPETITIVE LANDSCAPE 169
11.1 OVERVIEW 169
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 169
11.2.1 OVERVIEW OF KEY STRATEGIES ADOPTED BY PLAYERS IN NEAR-INFRARED IMAGING MARKET 169
11.3 REVENUE SHARE ANALYSIS 169
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022 170
11.4 MARKET SHARE ANALYSIS 170
FIGURE 29 MARKET SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022 170
TABLE 169 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION 171
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 172
11.5.1 STARS 172
11.5.2 EMERGING LEADERS 172
11.5.3 PERVASIVE PLAYERS 172
11.5.4 PARTICIPANTS 172
FIGURE 30 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 173
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 174
11.6.1 PROGRESSIVE COMPANIES 174
11.6.2 STARTING BLOCKS 174
11.6.3 RESPONSIVE COMPANIES 174
11.6.4 DYNAMIC COMPANIES 174
FIGURE 31 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 175
11.7 COMPETITIVE BENCHMARKING 176
TABLE 170 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF KEY PLAYERS 176
TABLE 171 PRODUCT FOOTPRINT OF COMPANIES 176
TABLE 172 GEOGRAPHICAL FOOTPRINT OF COMPANIES 177
11.8 COMPETITIVE SCENARIOS AND TRENDS 178
TABLE 173 KEY PRODUCT LAUNCHES 178
TABLE 174 KEY DEALS 178
TABLE 175 OTHER KEY DEVELOPMENTS 179
12 COMPANY PROFILES 180
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY PLAYERS 180
12.1.1 STRYKER 180
TABLE 176 STRYKER: COMPANY OVERVIEW 180
FIGURE 32 STRYKER: COMPANY SNAPSHOT (2022) 181
12.1.2 KARL STORZ SE & CO. KG 184
TABLE 177 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 184
12.1.3 CARL ZEISS MEDITEC AG 186
TABLE 178 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW 186
FIGURE 33 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022) 187
12.1.4 LEICA MICROSYSTEMS 189
TABLE 179 LEICA MICROSYSTEMS: COMPANY OVERVIEW 189
FIGURE 34 LEICA MICROSYSTEMS (DANAHER CORPORATION): COMPANY SNAPSHOT (2022) 190
12.1.5 OLYMPUS CORPORATION 193
TABLE 180 OLYMPUS CORPORATION: COMPANY OVERVIEW 193
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 193
12.1.6 SHIMADZU CORPORATION 196
TABLE 181 SHIMADZU CORPORATION: COMPANY OVERVIEW 196
FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2021) 197
12.1.7 PERKINELMER, INC. 199
TABLE 182 PERKINELMER, INC.: COMPANY OVERVIEW 199
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 200
12.1.8 LI-COR, INC. 202
TABLE 183 LI-COR, INC.: COMPANY OVERVIEW 202
12.1.9 HAMAMATSU PHOTONICS K.K. 204
TABLE 184 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW 204
FIGURE 38 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2022) 205
12.1.10 QUEST MEDICAL IMAGING B.V. 207
TABLE 185 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW 207
12.1.11 SIGMA-ALDRICH (MERCK) 208
TABLE 186 SIGMA-ALDRICH: COMPANY OVERVIEW 208
FIGURE 39 SIGMA-ALDRICH: COMPANY SNAPSHOT (2022) 208
12.1.12 MIZUHO MEDICAL CO., LTD. 210
TABLE 187 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW 210
12.1.13 TELEDYNE PRINCETON INSTRUMENTS 211
TABLE 188 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW 211
FIGURE 40 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2022) 212
12.1.14 THERMO FISHER SCIENTIFIC INC. 213
TABLE 189 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 213
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 214
12.1.15 FLUOPTICS 216
TABLE 190 FLUOPTICS: COMPANY OVERVIEW 216
12.1.16 MEDTRONIC 217
TABLE 191 MEDTRONIC: COMPANY OVERVIEW 217
12.1.17 CAYMAN CHEMICAL 218
TABLE 192 CAYMAN CHEMICAL: COMPANY OVERVIEW 218
12.1.18 MP BIOMEDICALS 219
TABLE 193 MP BIOMEDICALS: COMPANY OVERVIEW 219
12.1.19 CRYSTA-LYN CHEMICAL COMPANY 220
TABLE 194 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW 220
12.1.20 GOWERLABS LTD. 221
TABLE 195 GOWERLABS LTD.: COMPANY OVERVIEW 221
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES 222
12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC 222
12.2.2 XENICS NV 222
12.2.3 BIOTIUM 223
12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD. 224
12.2.5 AAT BIOQUEST, INC. 224
13 APPENDIX 225
13.1 DISCUSSION GUIDE 225
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 CUSTOMIZATION OPTIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232